Research progress of CAR-macrophages in malignant hematological diseases
10.3760/cma.j.cn121090-20231103-00248
- VernacularTitle:CAR-巨噬细胞在恶性血液病中的研究进展
- Author:
Rubing ZHENG
1
;
Yi XIAO
Author Information
1. 华中科技大学同济医学院附属同济医院血液科，武汉 430030
- From:
Chinese Journal of Hematology
2024;45(4):413-416
- CountryChina
- Language:Chinese
-
Abstract:
This article reviews the development history of chimeric antigen receptor macrophage (CAR-M) therapy, discusses its application in malignant hematologic diseases, introduces related clinical trials, analyzes the advantages and challenges faced by CAR-M therapy in clinical application, and looks forward to its future use in the treatment of malignant hematologic diseases.
